Vitamin B12 and Parkinson’s: What a New Genetic Study Reveals About the "Missing Link"

For a long time, there has been a great deal of interest in the relationship between vitamin B12 and Parkinson’s. Many observational studies have shown that people with the condition tend to have lower levels of B12 than those without it. Some scientists have even suggested that B12 might interact with alpha-synuclein—the protein that clumps in the Parkinson's brain—or modify the activity of the LRRK2 gene. Naturally, this leads to an important question: could low vitamin B12 actually be a cause of Parkinson’s, and could supplements help slow it down? A comprehensive new study published in Neurology Genetics on February 16, 2026, has taken a deep dive into the DNA of over 70,000 people to find the answer. Using advanced genetic tools, researchers looked to see if there is a "causal" link, meaning they investigated whether a genetic predisposition for certain B12 levels directly impacts the risk of developing Parkinson’s or the speed at which the condition progresses. The Genetic Investigation: Searching for the "Why" While previous studies looked at B12 levels in the blood, this team looked at the genetic blueprints for how our bodies handle the vitamin. They focused on several key genes that manage every step of the journey, including genes like CUBN and AMN that help the gut soak up B12, TCN2 which carries the vitamin through the bloodstream, and processing genes like MTR and MTRR that convert B12 into the active forms your cells use for energy and DNA repair. The researchers used a technique called Mendelian Randomisation. This acts as a "natural clinical trial" because we are born with our genes. If "low B12 genes" were always found in people with Parkinson’s, it would suggest that low B12 is a cause, not just a side effect. The Findings: A Surprising Disconnect Despite the strong evidence from earlier blood tests, this large-scale genetic study reached a very clear conclusion. There is no evidence of a genetic or causal link between vitamin B12 levels and Parkinson’s. Specifically, the study found that having "low B12 genes" did not increase the likelihood of getting a diagnosis, and B12 genetics did not determine whether someone developed symptoms earlier or later in life. Most importantly for those already diagnosed, the study found no evidence that B12 levels influenced how fast motor symptoms or cognitive changes progressed over time. This suggests that low B12 might be a consequence rather than a cause. Certain medications or changes in the gut and diet that happen after a diagnosis can lead to lower B12 levels. In this case, B12 is a "marker" that tells us something is happening in the body, but it isn't the "maker" or the cause of the condition itself. The Critical Connection: B12 and Dementia Risks While this genetic study clarifies that B12 does not cause Parkinson's, it is vital to follow the separate but related evidence regarding cognitive health. Clinical research consistently shows that low levels of vitamin B12 are a significant risk factor for cognitive impairment and dementia. In the general population, B12 deficiency is known to cause confusion and memory loss—symptoms that can often be mistaken for dementia but are sometimes reversible if treated early. For people with Parkinson's, this is particularly important because the condition already puts a strain on the brain's resources. A study from the Mayo Clinic found that people who had higher B12 levels at the time of their diagnosis were significantly less likely to develop dementia in the following years. Vitamin B12 is essential for maintaining myelin, the protective insulation around your brain cells. When B12 levels are low, this insulation wears thin, leading to white matter injury. This can manifest as slower thinking, difficulty with focus, and an increase in the risk of hallucinations. Furthermore, low B12 is often associated with high levels of an amino acid called homocysteine. High homocysteine is essentially a red flag for the brain, as it is linked to brain shrinkage and damage to small blood vessels, both of which increase the risk of dementia. Because medications like Levodopa can lower your B12 levels over time, regular monitoring is a vital part of staying resilient. A Guide to Identifying B12 Deficiency Recognising a deficiency early can prevent permanent neurological damage. Since many of these signs overlap with standard Parkinson's symptoms, it is important to look for specific red flags. Physical red flags often include numbness or tingling, frequently felt as "pins and needles" in the hands or feet. You may also notice a significant increase in balance issues or instability that feels separate from your usual symptoms. Other signs include a swollen, red, or unusually smooth tongue, and extreme fatigue or weakness caused by the body producing abnormally large red blood cells. Cognitive and mental red flags include sudden confusion or frequent memory gaps, such as forgetting familiar names or losing your train of thought more often than usual. Visual hallucinations can also be exacerbated by low B12. Additionally, be aware of new mood changes, such as a sudden onset of depression, apathy, or anxiety that doesn't seem to have an external trigger. To manage your levels effectively, ask your GP to check your B12 and homocysteine levels at least once a year. Aim for the higher end of the normal range, as the brain often needs more B12 than the rest of the body to function optimally. Focus on B12-rich foods like salmon, mackerel, eggs, and lean meats. If you have digestive issues or are on high doses of medication, you might consider sublingual sprays or injections, as these bypass the gut and enter the bloodstream directly. Consistently maintaining these levels is a simple but powerful way to protect your brain's insulation and help your backup systems bridge the gap.